Nagel, Ralf (Bremen (govt) 200906 Senator für Wirtschaft + Häfen RESIGNED) |
Minister |
Bremen (govt region) |
Germany |
Nagel, Roman |
n. a. |
ING (Group) |
Germany |
Naggert, Michael (Seleckt-ID Biolabs GmbH 201502 Managing Director) |
Managing Director |
selekt-ID Biolabs GmbH |
Germany |
Nagler, Peter (Evonik 201201 Chief Innovation Officer) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evonik (Group) |
Germany |
Nagy, Andras (Univ Toronto 202004 Professor at Samuel Lunenfeld Research Institute of Mount Sinai Hospital) |
President/Director/Head Business Group/Unit/Division |
University of Toronto |
Canada |
Nagy, Elisabeth (Univ Szeged 201203 Prof Dept of Clinical Microbiology) |
Professor |
University of Szeged |
Hungary |
Nagy, Eszter (Arsanis 201010– CSO + Co-founder before SVP Research at Intercell AG) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Arsanis (Group) |
Austria |
Nahas, Nasri G. (Spinomix 201506 CEO before GeneBio CEO) |
Chief Executive Officer (CEO) |
Spinomix S.A. |
Switzerland |
Nahavandi, Ali (Alna-Bioscience 201012 Managing Director + Founder) |
Managing Director |
Alna-Biscience GmbH & Co. KG |
Germany |
Naheta, Akshay (SoftBank 201708 Managing Director of SoftBank Group International) |
Chief Executive Officer (CEO) |
SoftBank (Group) |
|
Nakamoto, Akira (Shimadzu 201504– Board Chairma before CEO) |
Board member, non-executive |
Shimadzu (Group) |
Japan |
Nakamura, Koji (Chiome Bioscience 201710 Head Drug Discovery Labs before CEO of LivTech) |
Research & Development Manager |
Chiome Bioscience (Group) |
Japan |
Nakaya, Kazuya (Panasonic 201206 Executive Managing Director of Panasonic Healthcare Co., Ltd.) |
Managing Director |
PHC (Group) |
Japan |
Nakayama, Joji (Daiichi Sankyo 201512 CEO) |
Chief Executive Officer (CEO) |
Daiichi Sankyo (Group) |
Japan |
Nam, Kiyean (Qurient (KR) 201506 CEO) |
Chief Executive Officer (CEO) |
Qurient Co., Ltd. (KRX 115180) |
Korea, Republic of |
Naményi, Christof (AXA 201208 Managing Director of AXA Private Equity) |
Managing Director |
Ardian (Group) |
France |
Namouni, Fouad (BMS 201706 Head of Development Oncology) |
President/Director/Head Business Group/Unit/Division |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
Naraghi, Mohammad (Siemens Medical Solutions 200603 Head of Business Development) |
Business Development Manager / Strategy Manager |
Siemens (Group) |
Germany |
Narasimhan, Vasant (Vas) (Novartis 201408– Global Head Developm Novartis Pharma before Global Head Developm Vaccines |
Research & Development Manager |
Novartis (Group) |
United States (USA) |
Narayanan, Sabrina (Biofrontera 200801– Media-Scientific Expert before Galderma) |
n. a. |
Biofrontera (Group) |
Germany |
Nash, Andrew (Zenyth 200602 CEO) |
Chief Executive Officer (CEO) |
CSL (Group) |
Australia |
Nastos, Aristotelis (Creathor Ventures 201604 before NRW.Bank + Peppermint.) |
Investment Manager |
Creathor Ventures (Group) |
Germany |
Natanek, Rafael (Gilde Investment 201903c– Partner at Gilde Healthcare before Bain Consulting) |
Partner (venture partner) |
Gilde Investment (Group) |
Netherlands |
Nathrath, Daniel (Ada Health 201712 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Ada Health (Group) |
Germany |
Natsias, Konstantinos (CAMAG 201302 CEO) |
Chief Executive Officer (CEO) |
CAMAG (Group) |
Switzerland |
Nauck, Matthias (Univ Greifswald 201606 Professor + Baltic Analytics GmbH 201112 Managing Director) |
Managing Director |
Baltic Analytics GmbH |
Germany |
Navabi, Stefanie (Biometra 200710) |
n. a. |
Endress+Hauser (Group) |
Germany |
Naval, Jordi (Biocat 202003 CEO) |
Chief Executive Officer (CEO) |
Biocat (BioRegion of Catalonia Private Foundation / Fundació Privada BioRegió de Catalunya) |
Spain (España) |
Navid, Sasan (Virometix 202007 CFO before Amgen + Ernst & Young) |
Chief Financial Officer (CFO) |
Virometix AG |
|
Navon, Benjamin (W2O Group 201807) |
Public Relations Manager / Investor Relations Manager |
W2O Group (Group) |
United States (USA) |
Navot, Nir (Pronto Diagnostics 201010 CEO) |
Chief Executive Officer (CEO) |
Pronto Diagnostics Ltd. |
Israel |
Nawana, Namal (Alere 201602 CEO) |
Chief Executive Officer (CEO) |
Alere (Group) |
United States (USA) |
Nazabal, Alexis (CovalX 200902 CEO) |
Chief Executive Officer (CEO) |
CovalX (Group) |
Switzerland |
Neal, Rodney (Körber 201703– VP Strategic Program Management at Werum IT Solutions America) |
Sales Manager / Marketing Manager |
Körber (Group) |
Germany |
Nebel, Simon (Aravis 201401– Managing Partner + Founder) |
Managing Partner (investment firm) |
Aravis (Group) |
Switzerland |
Nechansky, Andreas (Vela Laboratories 201107 COO) |
Chief Operating Officer (COO) |
Vela pharmazeutische Entwicklung und Laboranalytik GmbH (Vela Laboratories) |
Austria |
Nederkoorn, Paul H. J. (Ostendum R&D BV 201401 CEO) |
Chief Executive Officer (CEO) |
Ostendum R&D B.V. |
Netherlands |
Neeleman, Christiaan (Definiens 201309– COO before among others Philips Healthcare) |
Chief Operating Officer (COO) |
AstraZeneca (Group) |
Germany |
Neermann, Jörg (200701– Life Sciences Partners also Kaneas Capital founder before DVC before Atlas Venture) |
Investment Manager |
Life Sciences Partners (LSP) |
Germany |
Nehls, Michael C. (Ingenium 200604 CEO) |
Chief Executive Officer (CEO) |
Vivoryon (Group) |
Germany |
Nehrbass, Ulf (Ksilink 201709 CEO before QurlentTherapeutics + Institut Pasteur Korea + Institut Pasteur Paris) |
Chief Executive Officer (CEO) |
Ksilink (FR) |
France |
Neil, Madeleine (Uppsala BIO 201109 Director of Communications) |
Public Relations Manager / Investor Relations Manager |
Uppsala BIO |
Sweden |
Neirinck, Dirk (Endress+Hauser 201510 Managing Director of Endress+Hauser Consult AG) |
Managing Director |
Endress+Hauser (Group) |
Switzerland |
Neiss, Ursula |
n. a. |
Roche (Group) |
Germany |
Nell, Peter (Mammoth Biosciences 202001c– CBO before Co-Founder of Casebia) |
Chief Business Officer (CBO) |
Mammoth Biosciences Inc. |
United States (USA) |
Nelson, Todd R. (eBioscience 200708– CEO before Invitrogen + RBC Capital Markets + Merrill Lynch) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
United States (USA) |
Nemeth, Balazs (IMMS GmbH 201406 Manager Bioanalytical + Biomedical Sensors) |
Researcher (university / research institute) |
Institut für Mikroelektronik- und Mechatronik-Systeme gGmbH (IMMS) |
Germany |
Nerger, Matthias (Nordrhein-Westfalen (govt) 2008–201204 Head of BIO.NRW Office LEFT 4/12) |
Cluster Manager |
Nordrhein-Westfalen (govt region) |
Germany |
Neri, Duccio (Philogen 201301 CEO) |
Chief Executive Officer (CEO) |
Philogen (Group) |
Italy |
Nesmith, Ken (Lexent Bio 202006 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Nessi, Claudio (NeoMed Management 201309) |
Investment Manager |
NeoMed (Group) |
United Kingdom (GB) |
Nestler, Klaus (Corporate Finance Partners 201402 Managing Director at CFP BioConnect AG) |
Managing Director |
Corporate Finance Partners (CFP) (Group) |
Germany |
Nestmann, Judith (Bayer 201507 Investor Relations Manager) |
Public Relations Manager / Investor Relations Manager |
Bayer (Group) |
Germany |
Nestorov, Peter (Scailyte 201901 CEO) |
Chief Executive Officer (CEO) |
Scailyte AG |
Switzerland |
Nettersheim, Michael (202009 ECBF General Partner before HTGF 200912 Investment Manager before MediGene AG) |
General Partner (venture partner) |
European Circular Bioeconomy Fund (ECBF) |
Germany |
Netzer, Rainer (Evotec 200011–201503 SVP BusDev before Batelle Memorial Institute before Roche) |
Business Development Manager / Strategy Manager |
Evotec (Group) |
Germany |
Netzer, Tilo (PharmaLex 201401– Managing Director/COO joined 201206 before Merck Serono) |
Managing Director |
PharmaLex (Group) |
Germany |
Neubauer, Gerd |
n. a. |
Industrie- und Handelskammer |
Germany |
Neubauer, Peter (TU Berlin 201208 Prof at Institute of Biotechnology, FG Bioverfahrenstechnik) |
Professor |
Technical University Berlin (TU Berlin) |
Germany |
Neubauer, Steffen (Omnilab 201204 Managing Director of Universal Laborservice GmbH) |
Managing Director |
Omnilab (DE) (Group) |
Germany |
Neubeck, Peter (Kurma Partners 201901 Partner + Head of Munich Office before TVM Capital + Novartis + McKinsey) |
Partner (venture partner) |
Kurma Partners, Munich Office |
Germany |
Neuberger, Ralph (HUMAN Diagnostics 201402 Managing Director) |
Managing Director |
HUMAN Diagnostics Worldwide (Group) |
Germany |
Neuefeind, Torsten (Proteros Biostructures 200610 Managing Director) |
Managing Director |
Proteros (Group) |
Germany |
Neuer, Katja (MLM Medical Labs 202007 Director Business Development + Aquisgranainvest 2020205– Managing Director) |
Business Development Manager / Strategy Manager |
MLM Medical Labs (Group) |
Germany |
Neugebauer, Julia (MorphoSys 202002 Director Corp Communications + IR) |
Public Relations Manager / Investor Relations Manager |
MorphoSys (Group) |
Germany |
Neuhaus, Eckhart (Advalytix co-founder) |
n. a. |
Danaher (Group) |
Germany |
Neuhaus, Gunther (Univ Freiburg 1999 Professor + Greenovation Biotech GmbH Co-founder) |
Professor |
University of Freiburg (Albert-Ludwigs-Universität Freiburg) |
Germany |
Neujahr, Martin (Bruker Corp 201612 Head Bruker Detection CBRN business unit) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
Neukirch, Falk (Vita 34 201902 CFO) |
Chief Financial Officer (CFO) |
Vita 34 (Group) |
Germany |
Neukom, Beat (Kuros Biosurgery 200808c– CFO before JnJ) |
Chief Financial Officer (CFO) |
Kuros (Group) |
Switzerland |
Neuman, Toomas (IPDx Immunoprofiling Diagnostics GmbH 201511– Managing Director) |
Managing Director |
IPDx Immunoprofiling Diagnostics GmbH |
Germany |
Neumann, Andreas (Boehringer 201510– Managing Director for HR joined 2011 as Head of Legal Dept + General Counsel) |
Human Resources Manager |
Boehringer Ingelheim (Group) |
Germany |
Neumann, Birgit (Bayer Technology Systems 200503) |
n. a. |
Bayer (Group) |
Germany |
Neumann, Björn (Monsanto 201304 Managing Director of Monsanto Agrar Deutschland GmbH) |
Managing Director |
Monsanto (Group) |
Germany |
Neumann, Lars (Proteros 201305 VP Discovery Projects + Project Manager) |
n. a. |
Proteros (Group) |
Germany |
Neumüller, Dirk (Biotest 201608 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Creat (Group) |
Germany |
Neusser, Marcus (Bio-Rad Laboratories GmbH 200512) |
n. a. |
Bio-Rad (Group) |
Germany |
Neusüß, Christian (Hochschule Aalen 201001 Professor Chemistry) |
Professor |
Hochschule Aalen – Technik und Wirtschaft |
Germany |
Neville, Lindsey (Consilium 201805) |
Public Relations Manager / Investor Relations Manager |
Consilium Strategic Communications Ltd. (CSC) |
United Kingdom (GB) |
Newble, David (TTP Group 201506– Managing Director of TTP Labtech before CEO of TAP Biosystems) |
Managing Director |
TTP Labtech (Group) |
United Kingdom (GB) |
Newell, William J. (Sutro Biopharma 201409 CEO) |
Chief Executive Officer (CEO) |
Sutro Biopharma Inc. |
United States (USA) |
Newland, Andrew (Angle plc 201409 CEO + Founder) |
Chief Executive Officer (CEO) |
Angle plc (AIM: AGL) |
United Kingdom (GB) |
Ney, Ursula M. (Genkyotex 201105– CEO before Antisoma COO before Charterhouse Therapeutics CEO) |
Chief Executive Officer (CEO) |
Genkyotex (Group) |
Switzerland |
Ng, Frankie (SGS 201505 CEO) |
Chief Executive Officer (CEO) |
SGS (Group) |
Switzerland |
Ni, Binhui (Ben) (BioLineRx 201708 CEO of iPharma) |
Chief Executive Officer (CEO) |
BioLineRx (Group) |
China |
Nicholls, Anthony (OpenEye Scientific 202005 CEO + Founder) |
Chief Executive Officer (CEO) |
OpenEye Scientific (Group) |
United States (USA) |
Nicholson, C. David (Bayer 201203– Head RnD at Bayer CropScience before Merck US + Schering-Plough + Organon) |
Research & Development Manager |
Bayer (Group) |
Germany |
Nicholson, David (Allergan 201604 EVP + President Global Brands RnD) |
Research & Development Manager |
Allergan (Group) |
Ireland, Republic of |
Nicholson, Jeremy (Murdoch Univ + ANPC 201909 Prof before Imperial College + MRC-NIHR Phenome Centre) |
Professor |
Murdoch University |
Australia |
Nickisch, Klaus (Evestra 200808– Managing Director of Evestra GmbH) |
Managing Director |
Evestra (Group) |
Germany |
Nickl, Wolfgang (Bayer 201804– CFO before ASML NV + Western Digital + Converge) |
Chief Financial Officer (CFO) |
Bayer (Group) |
Germany |
Nicklin, Peter (Bayer HealthCare 200508– Business Development) |
Business Development Manager / Strategy Manager |
Bayer (Group) |
Germany |
Nickolaus, Claudia (Mologen 201407– Head Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Mologen (Group) |
Germany |
Nicols, John (Codexis 201710 CEO) |
Chief Executive Officer (CEO) |
Codexis (Group) |
United States (USA) |
Nicosia, Alfredo (NousCom 201605–201905 CEO at NousCom Srl + Co-Founder before Okairos RETIRED 5/19) |
Chief Executive Officer (CEO) |
Nouscom (Group) |
Italy |
Niebel, Volker (Sartorius 201012 Board Member of Sartorius Stedim Biotech) |
Board member |
Sartorius (Group) |
Germany |
Niebling, Anna (AntiProt GmbH 2007) |
n. a. |
AntiProt GmbH |
Germany |
Niederfeld, Thomas (Avontec 200404– joined from Carl Zeiss) |
n. a. |
Avontec GmbH |
Germany |
Niedl, Anna (4SC 201710 Corp Communiations + IR Officer) |
Public Relations Manager / Investor Relations Manager |
4SC (Group) |
Germany |
Nielen, Michel W. F. (Wageningen Univ 201606 Professor) |
Professor |
Wageningen University |
Netherlands |